NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-55 Cr | ₹-7.48 Cr | ₹-21 Cr | ₹-2.80 Cr | ₹-12 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-55 Cr |
| Mar2024 | ₹-7.48 Cr |
| Mar2023 | ₹-21 Cr |
| Mar2022 | ₹-2.80 Cr |
| Mar2021 | ₹-12 Cr |
How is Deferred Tax Assets / Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-55 Cr | Negative | |
| Mar2024 | ₹-7.48 Cr | Negative | |
| Mar2023 | ₹-21 Cr | Negative | |
| Mar2022 | ₹-2.80 Cr | Negative | |
| Mar2021 | ₹-12 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹217.8 Cr | -0.7% | -3.4% | -46.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -0.7% |
-3.4% |
-46.4% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses